Clofibride
Product Specifications
UNSPSC Description
Clofibride is an orally active hypolipaemic agent of pchlorophenoxyisobutyric type. Clofibride has weak toxicity and marked hypocholesterolaemic and hypotriglyceridaemic activity. Clofibride is converted into 4-chlorophenoxyisobutyric acid (CPIB) and 4-hydroxy-N-dimethylbutyramide (HMB) in vivo[1].
Target Antigen
Glutathione S-transferase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/clofibride.html
Solubility
10 mM in DMSO
Smiles
CC(OC1=CC=C(C=C1)Cl)(C(OCCCC(N(C)C)=O)=O)C
Molecular Weight
327.80
References & Citations
[1]G P Loiseau, et al. On the metabolism of clofibride, a hypolipaemic drug. J Pharm Pharmacol. 1980 Jul;32(7):483-8.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-119524/Clofibride-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-119524/
Clinical Information
No Development Reported
CAS Number
26717-47-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7063052 Inquire
Recombinant Magnetococcus sp. NADH-quinone oxidoreductase subunit K (nuoK), partial
Ask
View Details abx327933-01 50 µg
Lymphoid Enhancer Binding Factor 1 Phospho-Ser42 (LEF1 pS42) Antibody
Ask
View Details 
abx327933-02 100 µg
Lymphoid Enhancer Binding Factor 1 Phospho-Ser42 (LEF1 pS42) Antibody
Ask
View Details 